Meet David Perry:
Founder & CEO
focused on health,
food & agriculture
David Perry is an entrepreneur who has founded and built five innovative companies in the last 20 years. He is currently the CEO of Indigo Agriculture, Co-Founder and Chairman of Better Therapeutics, and on the Board of Directors at Evelo Biosciences.
As an early colleague at Chemdex, I was fortunate to witness David's vision and pure creative force. I'd invest in everything David puts his heart and mind to.
– Jon Callaghan, Venture Capitalist
Mission & Vision
A few years ago, I had the opportunity to take a step back and think about how I wanted to spend the next phase of my career. Over the previous 2-3 years, I had developed an interest in food — how are we going to produce enough, how can we do it sustainably, and how can we help people make food choices that are better for their long term health? I decided to focus on addressing these big questions.
At Indigo, David is committed to harnessing nature to help farmers sustainably feed the planet. He believes that improving agricultural practices will have a big and positive impact on climate change. At Better Therapeutics, he is focused on preventing and reversing chronic disease through significant changes in diet towards healthier, more sustainable foods.
David is focused on various angles of consumer health including: producing more nutritious, traceable food at Indigo, treating and reversing metabolic disease based on how people eat at Better Therapeutics, and using naturally occurring microbes to prevent and treat disease at Evelo.
We must feed 10 billion people by 2050. To do this, we will need new technology and approaches to produce more food with fewer resources. David aims to transform the world of agriculture through Indigo, which was recognized in 2017 as one of the World Economic Forum's "Technology Pioneers." At Better Therapeutics, behavior science is blended with digital technologies, artificially intelligent agents, and dedicated health coaches to guide, support, and enable complex changes that last.
Growers' profit margins are razor thin. By re-imagining agriculture at Indigo, David helps growers earn more for producing quality crops.
David Perry was raised on his family's farm in rural Arkansas. He holds a BS from the University of Tulsa and an MBA from Harvard Business School. He also attended the United States Air Force Academy.
In 1995, while at Harvard Business School, David Perry co-founded Virogen, a biotechnology company focused on diagnostics.
While at Virogen, he felt that scientists spent a lot of time procuring life sciences products through conventional catalog ordering. So, in 1997, he founded Chemdex, headquartered in California. Chemdex was a business-to-business marketplace focused on the life sciences industry that sold laboratory chemicals and other scientific equipments online. David served as CEO of Chemdex and presided over its $130 million IPO as one of the first B2B eCommerce companies to go public.
In 1999, David also created the parent company of Chemdex, called Ventro Corporation, which was later sold to Nexprise. He served as its CEO and President until November 2001. During that time, David was named the 2000 Entrepreneur of the Year in Northern California by Ernst and Young.
"David has grown Indigo into a company with a clear mission and the potential to realize remarkable scientific and business value for the world."
-Noubar Afeyan, CEO Flagship Pioneering
In 2002, Perry co-founded Anacor Pharmaceuticals and served as its CEO for twelve years. The biopharmaceutical company was focused on developing novel small-molecule therapeutics to treat infectious and inflammatory diseases. In 2016, the company was acquired by Pfizer for $5.4 billion.
In 2015, Perry co-founded Better Therapeutics, a digital therapeutics company focused on preventing and reversing chronic disease through lifestyle changes. He is also on the Board of Directors of the human microbiome company, Evelo Biosciences.
In 2014, Indigo Agriculture was founded as Symbiota by Noubar Afeyan, David Berry, and Geoffrey von Maltzahn, led by CEO David Perry. In February 2016, the company was renamed Indigo Agriculture, establishing its global HQ in Boston and North American HQ in Memphis.
Indigo Agriculture improves grower profitability, environmental sustainability, and consumer health through the use of natural microbiology and digital technologies. To date, Indigo has raised over $850 million in equity with operations in 5 countries and 4 continents across millions of acres.
years’ experience building life sciences & tech companies
innovative companies founded
of those companies achieved multi-billion dollar valuations